Insights

Innovation and Product Development PharmaMax's strong focus on developing innovative, high-quality products for chronic conditions presents opportunities for partnerships in R&D collaborations, licensing agreements, or joint ventures to expand product pipelines and accelerate time-to-market in the Chinese and international markets.

Strategic Manufacturing Expansion The company's ongoing expansion to a larger cGMP facility indicates increased manufacturing capacity, offering potential sales opportunities for advanced pharmaceutical equipment, raw materials, and process optimization services to support their scaling operations.

International Collaboration Potential With a proven track record of partnering with US and EU companies, PharmaMax is positioned to seek new international partners for distribution, co-development, or technology transfer, especially as it expands its market reach in China for both prescription and consumer healthcare products.

Regulatory and IP Support PharmaMax benefits from privileges that aid in registration and IP protection, suggesting opportunities to provide specialized legal, regulatory consulting, or IP management services to streamline product approvals and safeguard innovations in China.

Market Positioning and Opportunities As a mid-sized company with a focus on high-value healthcare solutions in a rapidly growing market, PharmaMax has potential sales prospects in medical devices, biotechnology, and digital health solutions that complement its pharmaceutical portfolio and enhance its competitive stance.

PharmaMax Corporation Tech Stack

PharmaMax Corporation uses 8 technology products and services including CNZZ, Babel, Element UI, and more. Explore PharmaMax Corporation's tech stack below.

  • CNZZ
    Analytics
  • Babel
    Development
  • Element UI
    Javascript Frameworks
  • Vue.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • core-js
    Javascript Libraries
  • Python
    Programming Languages
  • Java
    Programming Languages

Media & News

PharmaMax Corporation's Email Address Formats

PharmaMax Corporation uses at least 1 format(s):
PharmaMax Corporation Email FormatsExamplePercentage
First.Last@pharmamaxcorp.comJohn.Doe@pharmamaxcorp.com
50%
First.Last@pharmamaxcorp.comJohn.Doe@pharmamaxcorp.com
50%

Frequently Asked Questions

What is PharmaMax Corporation's official website and social media links?

Minus sign iconPlus sign icon
PharmaMax Corporation's official website is pharmamaxcorp.com and has social profiles on LinkedIn.

What is PharmaMax Corporation's SIC code NAICS code?

Minus sign iconPlus sign icon
PharmaMax Corporation's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PharmaMax Corporation have currently?

Minus sign iconPlus sign icon
As of December 2025, PharmaMax Corporation has approximately 51 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Vp Of Analytical R&d, Head Of Quality: X. C.. Explore PharmaMax Corporation's employee directory with LeadIQ.

What industry does PharmaMax Corporation belong to?

Minus sign iconPlus sign icon
PharmaMax Corporation operates in the Pharmaceutical Manufacturing industry.

What technology does PharmaMax Corporation use?

Minus sign iconPlus sign icon
PharmaMax Corporation's tech stack includes CNZZBabelElement UIVue.jsjQuerycore-jsPythonJava.

What is PharmaMax Corporation's email format?

Minus sign iconPlus sign icon
PharmaMax Corporation's email format typically follows the pattern of First.Last@pharmamaxcorp.com. Find more PharmaMax Corporation email formats with LeadIQ.

When was PharmaMax Corporation founded?

Minus sign iconPlus sign icon
PharmaMax Corporation was founded in 2009.

PharmaMax Corporation

Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees

PharmaMax is a innovation powerhouse within the Chinese pharmaceutical and consumer healthcare industry. PharmaMax is dedicated to improving the health and quality of life of China’s residents through highly innovative, world class quality products to treat chronic conditions. Its international management team have developed and commercialized over 250 new products for the global marketplace.  

PharmaMax, founded in 2009 is based in Taizhou City, Jiangsu Province and New Jersey, USA. The privately held company is a China-American joint venture between Jiangsu Changtai LTD and PharmaMax USA. This structure provides the perfect blend of international quality, scientific standards and governance with the ability to execute flawlessly within the complex regulatory environment of China. 

The PharmaMax portfolio is focused on high value prescription and consumer healthcare products which treat chronic conditions.  In addition, PharmaMax strategically partners with a number of international companies from the US and EU to bring breakthorough products to the massive China marketplace. 

For other customers, it offers turn-key "concept to commercialization" capabilities and services. 

The PharmaMax facilities are strategically located in Taizhou City and within the Chinese Medical City (CMC).  Our current facility is 3,000 square meters of floor space for R&D, cGMP Manufacturing and Office Adminstration.  PharmaMax is expanding operations to a new 16,000 square meter cGMP facility and company headquarters in early 2015.

PharmaMax and its strategic partners benefit from a number of special privileges intended to facilitate and expedite registrations and approvals as well as support to protect against IP infringement in China.

Section iconCompany Overview

SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    PharmaMax Corporation's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    PharmaMax Corporation's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.